Overview
Temidayo Fadelu is an Oncologist in Boston, Massachusetts. His top areas of expertise are Breast Cancer and Pseudomyxoma Peritonei.
His clinical research consists of co-authoring 42 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
Locations
450 Brookline Ave, Boston, MA 02215
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Dana-Farber Cancer Institute
Daniel Deangelo is an Oncologist in Boston, Massachusetts. Dr. Deangelo is highly rated in 36 conditions, according to our data. His top areas of expertise are Systemic Mastocytosis, Acute Myeloid Leukemia (AML), Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant.
Dana-Farber Cancer Institute
Matthew Davids is an Oncologist in Boston, Massachusetts. Dr. Davids is highly rated in 20 conditions, according to our data. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Small Lymphocytic Lymphoma (SLL), Bone Marrow Transplant, and Bone Marrow Aspiration.
Massachusetts General Hospital
Jeremy Abramson is an Oncologist in Boston, Massachusetts. Dr. Abramson is highly rated in 28 conditions, according to our data. His top areas of expertise are Non-Hodgkin Lymphoma, B-Cell Lymphoma, Classical Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.
Frequently Asked Questions about Dr. Temidayo Fadelu
How do I make an appointment with Dr. Temidayo Fadelu?
You can book an appointment with Dr. Temidayo Fadelu by calling their office at 877-442-3324. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Temidayo Fadelu a top-rated expert for Breast Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Temidayo Fadelu is classified as an Experienced expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Temidayo Fadelu specialize in?
While Dr. Temidayo Fadelu is a Oncology, they have specific expertise in Breast Cancer, Pseudomyxoma Peritonei. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Temidayo Fadelu participate in research or clinical trials?
Yes. Dr. Temidayo Fadelu has published 42 articles and abstracts on conditions like Breast Cancer. You can view a list of Dr. Temidayo Fadelu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Temidayo Fadelu accept my insurance?
Dr. Temidayo Fadelu accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 877-442-3324 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Breast CancerDr. Fadelu isExperienced. Learn about Breast Cancer.
- Pseudomyxoma PeritoneiDr. Fadelu isExperienced. Learn about Pseudomyxoma Peritonei.